Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

Market Cap	300.00M
Revenue (ttm)	15.56M
Net Income (ttm)	-8.61M
Shares Out	250.00M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,795,086
Average Volume	2,038,031
Open	1.190
Previous Close	1.190
Day's Range	1.170 - 1.250
52-Week Range	0.615 - 1.850
Beta	0.62
RSI	51.22
Earnings Date	Mar 26, 2025

About EGX:SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry engages in the manufacture and sale of generic medicines in Egypt. It provides hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets, such as Claudol and Flamogen E.C.T. The company also offers OTCs, food supplements, and veterinary products, as well as medicine trials services. The company was founded in 2000 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 165
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: SIPC

Financial Performance

In 2023, EGX:SIPC's revenue was 13.31 million, a decrease of -26.88% compared to the previous year's 18.20 million. Earnings were 113,086, an increase of 670.55%.